Soluble PD-L1 as a Prognostic Factor for Immunotherapy Treatment in Solid Tumors: Systematic Review and Meta-Analysis

Soluble PD-L1 as a Prognostic Factor for Immunotherapy Treatment in Solid Tumors: Systematic Review and Meta-Analysis

Blocking the Programmed Cell Death Protein 1 (PD-1)/programmed death ligand-1 (PD-L1) axis has demonstrated great efficacy in cancer immunotherapy treatment and remains the central modality of immune targeting. To support the rational and tailored use of these drugs, it is important to identify reli...

Full description

Bibliographic Details
Main Authors: Fabio Scirocchi, Lidia Strigari, Alessandra Di Filippo, Chiara Napoletano, Angelica Pace, Hassan Rahimi, Andrea Botticelli, Aurelia Rughetti, Marianna Nuti, Ilaria Grazia Zizzari
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:International Journal of Molecular Sciences
Subjects:
programmed death ligand-1 (PD-L1)
soluble programmed death ligand-1 (sPD-L1)
soluble forms of IC receptors
immunotherapy
prognostic biomarker
survival
Online Access:https://www.mdpi.com/1422-0067/23/22/14496

Internet

https://www.mdpi.com/1422-0067/23/22/14496

Similar Items